Effect of Glucocorticoid and 11β-Hydroxysteroid-Dehydrogenase Type 1 (11β-HSD1) in Neurological and Psychiatric

Seetal Dodd1,2, David R Skvarc1,3, Olivia M Dean1,4

  • 1Deakin University, The Institute for Mental and Physical Health and Clinical Translation (IMPACT), School of Medicine, Barwon Health, Geelong, Australia.

Insights

11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) is a key enzyme in disease progression and a therapeutic target. Novel agents targeting 11β-HSD1 show potential for treating metabolic and neurological disorders, but more research is needed.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Endocrinology

Background:

  • 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) plays a crucial role in regulating active cortisol levels.
  • Dysregulation of 11β-HSD1 is linked to various diseases, including metabolic syndrome, type 2 diabetes, and neurodegenerative disorders.
  • 11β-HSD1 is an attractive therapeutic target for managing these conditions.

Purpose of the Study:

  • To summarize the enzymatic mechanisms of 11β-HSD1.
  • To review novel therapeutic agents targeting 11β-HSD1.
  • To evaluate the potential of 11β-HSD1 modulators in disease management.

Main Methods:

  • Literature review of enzymatic mechanisms.
  • Analysis of preclinical and clinical studies on novel 11β-HSD1 inhibitors and activators.
  • Examination of evidence for symptom management in various disease models.

Main Results:

  • 11β-HSD1 modulators affect peripheral cortisol and cortisone levels.
  • Agents show promise in models of hypertension, type 2 diabetes, metabolic disorders, and Alzheimer's disease.
  • Evidence for clinical symptom management is mixed, with emerging data in psychiatric and neurological conditions.

Conclusions:

  • 11β-HSD1 is a significant therapeutic target with potential applications across multiple medical fields.
  • Novel agents modulating 11β-HSD1 activity warrant further investigation for their efficacy in disease treatment.
  • More research is required to establish the clinical utility of 11β-HSD1 modulators, particularly in psychiatry and neurology.

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
232
Hypothalamic-Pituitary Axis01:37

Hypothalamic-Pituitary Axis

The response to stress—be it physical or psychological, acute or chronic—involves activation of the Hypothalamic-Pituitary-Adrenal (HPA) axis. The HPA axis is part of the neuroendocrine system because it involves both neuronal and hormonal communication. Its function is to regulate homeostatic systems—metabolic, cardiovascular, and immune—providing the necessary means to respond to a stressor.
62.3K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.6K
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.9K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
1.1K
Hormones of the Adrenal Glands01:31

Hormones of the Adrenal Glands

Adrenal hormones play a pivotal role in maintaining the body's electrolyte balance and orchestrating responses to stress, showcasing the intricate functions of the adrenal cortex and medulla.
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and...
3.0K